SCHEMBL20741027

SCHEMBL20741027

C[C@@H](c1ccccc1)N(CC(=O)NO)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 1/20 0.44
PDE4D Q08499 1/20 0.44
MMP1 P03956 3/20 0.44
MMP2 P08253 3/20 0.44
MMP3 P08254 3/20 0.44
MMP9 P14780 3/20 0.44
MMP8 P22894 3/20 0.44
MMP13 P45452 3/20 0.44
MMP14 P50281 3/20 0.44
ADAM17 P78536 1/20 0.44
ALOX5 P09917 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
MTOR P42345 1/20 0.43
MMP16 P51512 1/20 0.42
HDAC8 Q9BY41 5/20 0.41
HDAC3 O15379 4/20 0.41
HDAC1 Q13547 4/20 0.41
HDAC2 Q92769 4/20 0.41
NCOR2 Q9Y618 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20741030 1.00 SLC6A3 (0.44) SLC6A3PDE4DMMP1MMP2MMP3
SCHEMBL20741072 0.82 MTOR (0.40) SLC6A3PDE4DMMP1MMP2MMP3
SCHEMBL20741073 0.82 MTOR (0.40) SLC6A3PDE4DMMP1MMP2MMP3
SCHEMBL2479871 0.78 ALOX5 (0.50) ALOX5MEN1KMT2AMTORTSHR
SCHEMBL15655258 0.76 ALOX5 (0.49) ALOX5MEN1KMT2AMTORTRPM8
SCHEMBL15632903 0.76 ALOX5 (0.49) ALOX5MEN1KMT2AMTORTRPM8
SCHEMBL15632902 0.76 ALOX5 (0.49) ALOX5MEN1KMT2AMTORTRPM8
SCHEMBL15655256 0.76 ALOX5 (0.49) ALOX5MEN1KMT2AMTORTRPM8
SCHEMBL15633008 0.76 ALOX5 (0.49) ALOX5MEN1KMT2AMTORTRPM8
SCHEMBL28032109 0.75 ALOX5 (0.47) ALOX5MEN1KMT2AMTORTRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3676263-B1 3-HYDROXY-IMIDAZOLIDIN-4-ONE COMPOUNDS AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE NETHERLANDS TRANSLATIONAL RES CENTER B V (NL) 2021-10-06 EP disclosed
US-11053230-B2 3-hydroxy-imidazolidin-4-one compounds as inhibitors of indoleamine 2,3-dioxygenase NETHERLANDS TRANSLATIONAL RESEARCH CENTER B.V. 2021-07-06 US disclosed
US-20200181128-A1 3-HYDROXY-IMIDAZOLIDIN-4-ONE COMPOUNDS AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE NETHERLANDS TRANSLATIONAL RESEARCH CENTER B.V. (NL) 2020-06-11 US disclosed
EP-3426638-B1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE NETHERLANDS TRANSLATIONAL RES CENTER B V (NL) 2020-05-06 EP disclosed
US-20190055213-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE NETHERLANDS TRANSLATIONAL RESEARCH CENTER B.V. (NL) 2019-02-21 US disclosed
CN-109071457-A Inhibitors of indoleamine 2, 3-dioxygenase 荷兰转化研究中心有限责任公司 2018-12-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190055213-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE IDO1, IDO2, TPH2 SLC6A3 35/4885PDE4D 2592/4885MMP1 720/4885
US-11053230-B2 3-hydroxy-imidazolidin-4-one compounds as inhibitors of indoleamine 2,3-dioxygenase IDO1, IDO2, TPH1 SLC6A3 102/4885PDE4D 1868/4885MMP1 755/4885
US-20200181128-A1 3-HYDROXY-IMIDAZOLIDIN-4-ONE COMPOUNDS AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE IDO1, IDO2, TPH1 SLC6A3 102/4885PDE4D 1868/4885MMP1 755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.